So much of the work on health care utilization and spending has been done based on Medicare data and the Health Care Cost Institute, which was founded by and has data from and number of large commercial health plans, has done a very good service in rectifying that. The Institute has released its report on 2012 spending, which covers persons under 65 with employer-sponsored insurance. (HCCI Report) For 2012, overall per capita growth was 4% to $4701 annually. This was a slight decrease from 2011’s 4.1% growth, but still higher than either GDP growth or the rate of general inflation. Among major service categories, hospital inpatient had a 2.4% per capita increase, which was comprised of a 2.9% decline in admissions, but a 5.4% increase in prices paid. Outpatient facility spending rose by 7.4%, with a 1.4% growth in utilization and a 6% gain in prices. Outpatient testing grew 5.1%. Professional fees, primarily to physicians, showed only 3.1% growth, with utilization increasing 1.9% and prices only 1.1%. Prescription drug use increased 7.7% for generics but declined 20.7% for brand name drugs. Prices for generics rose 5.3% and 25.4% for brand names. The generic drug price increases are leading to higher overall spending in this category. Out-of-pocket spending grew 4.8% while the payer portion rose only 3.8%, reflecting continued growth in high-deductible and higher copay plans. Per capita spending by women grew faster than for men and spending by young adults and children was relatively slower than that for other age groups. The Northeast has both the highest per capita spending and the fastest growth while the West has the lowest spending and slowest growth. Overall the report reflects the general slowdown in spending, with prices still increasing at a rate that should be concerning. The effect of reform on spending growth in 2014 is unclear. Most people will still be in plans with higher cost-sharing, but more people supposedly will be insured, which might raise per capita utilization.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 18, 2024
Progress Against Cancer
The US has made particularly good progress in treating cancer and limiting mortality, but much…
Commentary
April 17, 2024
I Am Done With Coronamonomania, Part 4, Vax Safety Edition
A somewhat lengthy examination of recent studies related mostly to vax safety, the results of…
Commentary
April 16, 2024
Concentration of US Health Spending
Another version of my favorite brief on who is responsible for health is out, with…